GGAL Stock Recent News Grupo Financiero Galicia S.A. (GGAL) 14.07

New Post Public Reply Private Reply Replies (0) Message Board

Aug 5, 2014 at 11:17 PM

Grupo Financiero Galicia S.A. (GGAL) 14.07 $GGAL

As Argentina Defaults on Debt, Investors Flee from Stocks - Analyst Blog
Nilanjan Choudhury - Zacks Investment Research - Fri Aug 01, 3:26PM CDT
Investors deserted Argentina-based stocks following the country's second default of the 2000s.

Argentina ETF Tumbles on Default - ETF News And Commentary
Sweta Killa - ZACKS - Fri Aug 01, 1:00PM CDT
Argentina second default in 13 years send the stocks and ETF tumbling.

Why Banco Macro (BMA) Stock Is Slumping Today
at The Street - Thu Jul 31, 11:57AM CDT
Banco Macro (BMA) stock is falling after Argentina defaulted on its debt for the second time in 13 years.

WEALTHMAKERS.COM Issues Bullish Research Reports on FMBH, GGAL, GPI, IPGP, KGC, LMNR
M2 - Thu Jul 31, 8:22AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: First Mid-Illinois Bancshares Inc (OTCBB:FMBH), Grupo Financiero Galicia SA (NASDAQ:GGAL), Group 1 Automotive Inc (NYSE:GPI), IPG Photonics Corp (NASDAQ:IPGP), KINROSS GOLD CORP (NYSE:KGC), Limoneira Co (NASDAQ:LMNR)

Argentine Stocks Climb On Default Resolution Talks
at Investor's Business Daily - Wed Jul 30, 1:35PM CDT
It's the last straw for Argentina, which has until the end of the day Wednesday to reach a deal with U.S. bondholders to avoid its second default in 13 years. Stocks in the country soared on the prospect of a resolution. BBVA Banco Frances (BFR) led...

Trade-Ideas: Grupo Financiero Galicia (GGAL) Is Today's "Dead Cat Bounce" Stock
at The Street - Tue Jul 22, 9:01AM CDT
Trade-Ideas LLC identified Grupo Financiero Galicia (GGAL) as a "dead cat bounce" (down big yesterday but up big today) candidate

Uptrend Call Working As Grupo Financiero Galicia Stock Rises 13.0% (GGAL)
Comtex SmarTrend(R) - Thu Jul 17, 9:30AM CDT
SmarTrend identified an Uptrend for Grupo Financiero Galicia (NASDAQ:GGAL) on June 23rd, 2014 at $14.62. In approximately 3 weeks, Grupo Financiero Galicia has returned 13.00% as of today's recent price of $16.52.

Grupo Financiero Galicia Has Returned 11.7% Since SmarTrend Recommendation (GGAL)
Comtex SmarTrend(R) - Thu Jul 10, 9:33AM CDT
SmarTrend identified an Uptrend for Grupo Financiero Galicia (NASDAQ:GGAL) on June 23rd, 2014 at $14.62. In approximately 2 weeks, Grupo Financiero Galicia has returned 11.70% as of today's recent price of $16.33.

Grupo Financiero Galicia (GGAL) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 10, 8:28AM CDT
Grupo Financiero Galicia (GGAL) Shares March Higher, Can It Continue?

Argentina's Merval Index High On Debt Speculation
at Investor's Business Daily - Wed Jul 09, 6:04PM CDT
All eyes were on Argentina as it took on the Netherlands in the FIFA World Cup semifinals on Wednesday. Win or lose, investors would agree that the South American country's stock market is already a winner. The Merval index on the Buenos Aires...

What Will Happen to These ADRs if Argentina Defaults?
Louie Grint, The Motley Fool - Motley Fool - Thu Jun 26, 1:09PM CDT
Argentina is facing fresh economic turmoil. Last Monday, the U.S. Supreme Court declined to hear Argentina's appeal to avoid paying $1.33 billion to hedge fund creditors, letting stand lower court rulings that ordered the country to pay. Given...

The Zacks Analyst Blog Highlights:BBVA Banco Frances, YPF, Grupo Financiero Galicia, Trinity Industries, Canadian Natural Resources and Columbus McKinnon
PR Newswire - Wed Jun 25, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the BBVA Banco Frances S.A. (NYSE:BFR-Free Report), YPF S.A. (NYSE:YPF-Free Report), Grupo Financiero Galicia S.A. (Nasdaq:GGAL-Free Report), Trinity Industries (NYSE:TRN-Free Report), Canadian Natural Resources (NYSE:CNQ-Free Report) and Columbus McKinnon (Nasdaq:CMCO-Free Report).

Grupo Financiero Rises, Despite Argentina Debt Drama
at Investor's Business Daily - Tue Jun 24, 5:36PM CDT
The Merval index on the Buenos Aires exchange dipped 1% Tuesday. The index is up a robust 47% so far this year. That performance has played out despite Argentina's grind toward a month-end deadline that will determine whether the country reverts into...

Argentina's Default Worries: 3 Stocks in Focus - Analyst Blog
Swarup Gupta - Zacks Investment Research - Tue Jun 24, 11:40AM CDT
As things stand, Argentina is headed for a sovereign default, a virtual replay of the events of 2001.

4 Stocks Rising on Unusual Volume
at The Street - Tue Jun 24, 5:00AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Shares of GGAL Up 62.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jun 12, 11:00AM CDT
SmarTrend identified an Uptrend for Grupo Financiero Galicia (NASDAQ:GGAL) on February 12th, 2014 at $8.69. In approximately 4 months, Grupo Financiero Galicia has returned 62.35% as of today's recent price of $14.10.

Grupo Financiero (GGAL) Crumbles: Stock Falls by 8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jun 12, 8:00AM CDT
Grupo Financiero saw a big move last session on pretty good volume with far more shares changing hands than in a normal session; shares fell over 8% on the day.

Non-U.S. Bank Stocks Clear Winners After ECB Rate Cut
at Investor's Business Daily - Fri Jun 06, 4:58PM CDT
European markets rose with slightly less gusto than their U.S. counterparts for the week, buoyed by the European Central Bank's aggressive deflation-fighting measures and a healthy U.S. payrolls reports. The Stoxx Europe 600 added 0.7% last week. The...

Uptrend Call Working As Grupo Financiero Galicia Stock Rises 65.1% (GGAL)
Comtex SmarTrend(R) - Thu Jun 05, 10:12AM CDT
SmarTrend identified an Uptrend for Grupo Financiero Galicia (NASDAQ:GGAL) on February 12th, 2014 at $8.69. In approximately 4 months, Grupo Financiero Galicia has returned 65.11% as of today's recent price of $14.34.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Portillo's Faces Class Action: Investor Losses at Stake

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Investors Gear Up for Lennar Class Action Lawsuit

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Viking Ventures: Impacts of VK2735 on Obesity Examined

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...